Intermittent left bundle branch block and acute heart failure in trastuzumab-induced cardiotoxicity
- PMID: 32723779
- PMCID: PMC7389772
- DOI: 10.1136/bcr-2020-236009
Intermittent left bundle branch block and acute heart failure in trastuzumab-induced cardiotoxicity
Abstract
A 70-year-old woman with HER2+/ER+ breast cancer on adjuvant trastuzumab therapy without a history of cardiovascular disease presented with respiratory failure from influenza and was found to have intermittent left bundle branch block (LBBB) with new onset systolic heart failure. Her course was complicated by polymorphic ventricular tachycardia and recurrent chest pain. Significant investigations included a normal cardiac MRI and cardiac catheterisation with unobstructed coronaries. It was determined that the aetiology of her heart failure was trastuzumab-induced cardiotoxicity after comprehensive workup. This case highlights an uncommon presentation of LBBB and the steps taken to diagnose a rare cardiomyopathy.
Keywords: breast cancer; cancer - see oncology; chemotherapy; heart failure; unwanted effects / adverse reactions.
© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures




References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous